BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 38520598)

  • 1. Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer.
    Anderson JN; Paladino AJ; Blue R; Dangerfield DT; Eggly S; Martin MY; Schwartzberg LS; Vidal GA; Graetz I
    J Cancer Surviv; 2023 Dec; ():. PubMed ID: 38114711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study of Black breast cancer previvors' and survivors' experiences after positive genetic testing.
    Sud M; Stallings E; Wang C; Sosa LT
    J Genet Couns; 2024 Jun; ():. PubMed ID: 38845384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers.
    Lee KT; Gonzalez BD; Geiss C; Fulton HJ; Charles D; Vadaparampil ST; Henry NL; Jim HSL; Hershman DL; Tworoger SS; Gwede CK
    J Cancer Surviv; 2024 Mar; ():. PubMed ID: 38520598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.
    Spencer JC; Reeve BB; Troester MA; Wheeler SB
    Psychooncology; 2020 Apr; 29(4):647-654. PubMed ID: 32048400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors.
    Ashing-Giwa KT; Padilla G; Tejero J; Kraemer J; Wright K; Coscarelli A; Clayton S; Williams I; Hills D
    Psychooncology; 2004 Jun; 13(6):408-28. PubMed ID: 15188447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational Interviewing Counseling to Increase Endocrine Therapy Adherence in Diverse Patients.
    Wheeler SB; Spencer J; Drier SW; Fray N; Reeder-Hayes KE
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management.
    Samuel CA; Turner K; Donovan HAS; Beckjord E; Cardy A; Dew MA; van Londen GJ
    Support Care Cancer; 2017 Dec; 25(12):3723-3731. PubMed ID: 28681126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in Time to Treatment for Breast Cancer: Existing Knowledge and Future Directions in the COVID-19 Era.
    Fasano GA; Bayard S; Gillot T; Hannibal Z; Pedreira M; Newman L
    Curr Breast Cancer Rep; 2022; 14(4):213-221. PubMed ID: 36530340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Endocrine Therapy and Racial Outcome Disparities in Breast Cancer.
    Reeder-Hayes KE; Troester MA; Wheeler SB
    Oncologist; 2021 Nov; 26(11):910-915. PubMed ID: 34582070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
    Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Wood WC; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Berenberg JL; Abrams J; Sledge GW; Sparano JA
    J Natl Cancer Inst; 2021 Apr; 113(4):390-399. PubMed ID: 32986828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer.
    Lee KT; Jacobs L; Walsh EM; Stearns V; Segal JB
    Breast Cancer Res Treat; 2020 Dec; 184(3):965-975. PubMed ID: 32914353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
    Hershman DL; Unger JM; Hillyer GC; Moseley A; Arnold KB; Dakhil SR; Esparaz BT; Kuan MC; Graham ML; Lackowski DM; Edenfield WJ; Dayao ZR; Henry NL; Gralow JR; Ramsey SD; Neugut AI
    J Clin Oncol; 2020 Jul; 38(19):2122-2129. PubMed ID: 32369401
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.